Literature DB >> 20177105

Perifissural nodules seen at CT screening for lung cancer.

Myeong I Ahn1, Tadhg G Gleeson, Ida H Chan, Annette M McWilliams, Sharyn L Macdonald, Stephen Lam, Sukhinder Atkar-Khattra, John R Mayo.   

Abstract

PURPOSE: To describe and characterize the potential for malignancy of noncalcified lung nodules adjacent to fissures that are often found in current or former heavy smokers who undergo computed tomography (CT) for lung cancer screening.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Baseline and follow-up thin-section multidetector CT scans obtained in 146 consecutive subjects at high risk for lung cancer (age range, 50-75 years; > 30 pack-year smoking history) were retrospectively reviewed. Noncalcified nodules (NCNs) were categorized according to location (parenchymal, perifissural), shape, septal connection, manually measured diameter, diameter change, and lung cancer outcome at 7(1/2) years.
RESULTS: Retrospective review of images from 146 baseline and 311 follow-up CT examinations revealed 837 NCNs in 128 subjects. Of those 837 nodules, 234 (28%), in 98 subjects, were adjacent to a fissure and thus classified as perifissural nodules (PFNs). Multiple (range, 2-14) PFNs were seen in 47 subjects. Most PFNs were triangular (102/234, 44%) or oval (98/234, 42%), were located inferior to the carina (196/234, 84%), and had a septal connection (171/234, 73%). The mean maximal length was 3.2 mm (range, 1-13 mm). During 2-year follow-up in 71 subjects, seven of 159 PFNs increased in size on one scan but were then stable. The authors searched a lung cancer registry 7(1/2) years after study entry and found 10 lung cancers in 139 of 146 study subjects who underwent complete follow-up; none of these cancers had originated from a PFN.
CONCLUSION: PFNs are frequently seen on screening CT scans obtained in high-risk subjects. Although PFNs may show increased size at follow-up CT, the authors in this study found none that had developed into lung cancer; this suggests that the malignancy potential of PFNs is low. (c) RSNA, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20177105     DOI: 10.1148/radiol.09090031

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial.

Authors:  Marjolein A Heuvelmans; Matthijs Oudkerk; Pim A de Jong; Willem P Mali; Harry J M Groen; Rozemarijn Vliegenthart
Journal:  Eur Radiol       Date:  2014-11-04       Impact factor: 5.315

2.  [Radiological evaluation of incidental pulmonary nodules].

Authors:  H Prosch; C Schaefer-Prokop
Journal:  Radiologe       Date:  2013-07       Impact factor: 0.635

Review 3.  Screening for lung cancer with low-dose computed tomography: a review of current status.

Authors:  Henry M Marshall; Rayleen V Bowman; Ian A Yang; Kwun M Fong; Christine D Berg
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 4.  Management of incidental lung nodules <8 mm in diameter.

Authors:  Marcelo Sánchez; Mariana Benegas; Ivan Vollmer
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 5.  [Conventional and CT diagnostics of bronchial carcinoma].

Authors:  C Schaefer-Prokop
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

6.  Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT.

Authors:  Mark M Hammer; Eduardo J Mortani Barbosa
Journal:  Eur Radiol       Date:  2016-10-31       Impact factor: 5.315

7.  Probability of cancer in pulmonary nodules detected on first screening CT.

Authors:  Annette McWilliams; Martin C Tammemagi; John R Mayo; Heidi Roberts; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; Simon Martel; Francis Laberge; Michel Gingras; Sukhinder Atkar-Khattra; Christine D Berg; Ken Evans; Richard Finley; John Yee; John English; Paola Nasute; John Goffin; Serge Puksa; Lori Stewart; Scott Tsai; Michael R Johnston; Daria Manos; Garth Nicholas; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Alain Tremblay; Paul Burrowes; Paul MacEachern; Rick Bhatia; Ming-Sound Tsao; Stephen Lam
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 8.  Lung cancer screening: nodule identification and characterization.

Authors:  Ioannis Vlahos; Konstantinos Stefanidis; Sarah Sheard; Arjun Nair; Charles Sayer; Joanne Moser
Journal:  Transl Lung Cancer Res       Date:  2018-06

9.  Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease.

Authors:  Alexander Goehler; Pamela M McMahon; Heidi S Lumish; Carol C Wu; Vidit Munshi; Michael Gilmore; Jonathan H Chung; Brian B Ghoshhajra; Daniel Mark; Quynh A Truong; G Scott Gazelle; Udo Hoffmann
Journal:  Circulation       Date:  2014-07-11       Impact factor: 29.690

10.  Lung cancer screening with low-dose computed tomography.

Authors:  Caroline Chiles
Journal:  Radiol Clin North Am       Date:  2014-01       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.